N06BA12 - search results

lisdex teva 50 mg

teva israel ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - lisdex teva is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above. lisdex teva is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years. limitation of use: lisdex teva is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of lisdex teva for the treatment of obesity have not been established.

Israel - English - Ministry of Health

lisdex teva 60 mg

teva israel ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 60 mg - lisdexamfetamine - lisdex teva is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above. lisdex teva is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years. limitation of use: lisdex teva is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of lisdex teva for the treatment of obesity have not been established.

Israel - English - Ministry of Health

lisdex teva 70 mg

teva israel ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 70 mg - lisdexamfetamine - lisdex teva is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above. lisdex teva is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years. limitation of use: lisdex teva is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of lisdex teva for the treatment of obesity have not been established.